🚨 LIVE from #ASCO25 🚨
Dr. Erika Hamilton presents first-in-human data on Emi-Le (B7-H4 ADC) in solid tumors.

🔹 ORR: 31% in B7-H4 high
🔹 ORR: 44% w/ ≤4 prior lines
🔹 ACC-I: 55.6% ORR

Promising activity + tolerability in mBC, OC, EC & ACC-I.
#SCRI #ADC #Oncology #ASCO2025

Dr. Meredith McKean delivers her oral presentation on Novel Targets in #Melanoma Treatment at #ASCO2025

@scarrigan62.bsky.social Welcome!!